| Literature DB >> 6084318 |
P B Armstrong, J Levin, J P Quigley.
Abstract
Blood clotting in Limulus is dependent on the activity of a proteinase which converts the zymogen, coagulogen, into a form that undergoes polymerization to form the clot. The abilities of a series of recently discovered endogenous proteinase inhibitors to inhibit this enzyme and thereby serve as potential regulators of its activity were explored. The blood plasma of Limulus contains a single inhibitor that is functionally and structurally homologous to vertebrate alpha 2 macroglobulin. During exocytosis, the blood cells (amebocytes) release a series of inhibitors, including small quantities of the alpha 2 macroglobulin homologue; a low molecular weight, acid-and heat-stable inhibitor; and an acid acid-labile activity. Of the three inhibitory activities, only the cell-released, acid-labile inhibitor is capable of inhibiting the clotting enzyme.Entities:
Mesh:
Substances:
Year: 1984 PMID: 6084318
Source DB: PubMed Journal: Thromb Haemost ISSN: 0340-6245 Impact factor: 5.249